Alternating hepatic arterial infusion and systemic chemotherapy for liver metastases from colorectal cancer: A phase II trial using intermittent percutaneous hepatic arterial access

Journal of Clinical Oncology

Volumn 19, Issue 9, 2001, Pages 2404-2412

  Copur, M S ^a   Capadano, M ^a   Lynch, J ^a   Goertzen, T ^a   McCowan, T ^a   Brand, R ^a   Tempero, M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLOXURIDINE; FLUOROURACIL; FOLINIC ACID;

ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTINUOUS INFUSION; FEMALE; HEPATIC ARTERY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TECHNIQUE; TREATMENT OUTCOME; VASCULAR ACCESS;

EID: 0035339929     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.9.2404     Document Type: Article

References (34)

1. Cancer statistics 2000
2. Haematogenous metastatic patterns in colonic carcinoma: An analysis of 1541 necropsies
3. Prognostic index for the development of liver metastases in patients with colorectal cancer
4. Assessment of treatment of intrahepatic malignancies using chemotherapy via an implantable pump
5. Long-term hepatic arterial infusion chemotherapy: Anatomic considerations, operative techniques, and treatment morbidity
6. Regional chemotherapy of colorectal cancer metastases to the liver
7. Continuous regional chemotherapy for metastatic colorectal cancer using a totally implantable infusion pump: A feasibility study in 50 patients
8. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver: Is there a survival difference? Meta-analysis of the published literature
9. Randomized multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxy-uridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma
10. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
11. Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colon adenocarcinomas in mice
12. Overview of clinical trials using 5-FU and leucovorin for the treatment of colorectal cancer
13. A phase II trial of protracted therapy with 5-fluorouracil and daily oral leucovorin in metastatic colorectal carcinoma
14. Continuous regional treatment with fluorophyrimidines for metastases from colorectal carcinomas: Influence of modulation with leucovorin
15. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma
16. Optimal two-stage designs for phase II clinical trials
17. Nonparametric estimation from incomplete observation
18. Is hepatic infusion of chemotherapy effective treatment for liver metastases? No!
19. Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes!
20. Is intra-arterial chemotherapy worthwhile in the treatment of patients with unresectable hepatic colorectal cancer metastases?
21. Waiting for the definitive trial of hepatic arterial chemotherapy for colorectal cancer
22. Reappraisal of hepatic arterial infusion in the treatment of non-resectable liver metastases from colorectal cancer
23. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with non-resectable liver metastases from colorectal carcinoma
24. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
25. Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: Influence of modulation with leucovorin
26. Hepatic arterial floxuridine and leucovorin for unresectable liver metastases from colorectal carcinoma
27. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin
28. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver
29. Regional hepatic arterial chemotherapy for colorectal cancer metastatic to the liver: The controversy continues
30. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer
31. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial
32. Thymidylate synthase gene amplification in human colon cancer cell lines resistant to 5-fluorouracil
33. Thymidylate synthase protein expression in advanced colon cancer: Correlation with the site of metastasis and clinical response to leucovorin modulated bolus 5-fluorouracil